See every side of every news story

Published 6 days ago • loading... • Updated 6 days ago

Pharma majors expand US manufacturing amid tariff pressures as BRICS boost biosimilar access, reveals GlobalData

Summary by GlobalData

Major pharmaceutical companies including Eli Lilly, Pfizer, and Merck are ramping up manufacturing investments in the US to navigate the evolving trade tariffs and capitalize on domestic tax incentives. While this strategic shift supports supply chain resilience, it may also elevate production costs and drug prices—raising concerns around affordability as emerging markets pursue regulatory reforms to boost access to biosimilars and biologics, sa…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

Pharma majors expand US manufacturing amid tariff pressures as BRICS boost biosimilar access, reveals GlobalData

Major pharmaceutical companies including Eli Lilly, Pfizer, and Merck are ramping up manufacturing investments in the US to navigate the evolving trade tariffs and capitalize on domestic tax incentives. While this strategic shift supports supply chain resilience, it may also elevate production costs and drug prices—raising concerns around affordability as emerging markets pursue regulatory reforms to boost access to biosimilars and biologics, sa…

6 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated5 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GlobalData broke the news in 6 days ago on Tuesday, April 1, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content. Stay informed with comprehensive global news coverage all in one place. Subscribe now to compare different perspectives, identify biases, and stay ahead of algorithms